Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.75 |
| ▸ | TP53 | P04637 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.75 |
| ▸ | P2RY1 | P47900 | 6/20 | 0.73 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.73 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.73 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | SRC | P12931 | 1/20 | 0.73 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.73 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | LDHA | P00338 | 1/20 | 0.72 |
| ▸ | LDHB | P07195 | 1/20 | 0.72 |
| ▸ | MACROD2 | A1Z1Q3 | 1/20 | 0.69 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.69 |
| ▸ | MACROD1 | Q9BQ69 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25792100 | 1.00 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL8188 | 1.00 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL29350404 | 1.00 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL1276381 | 1.00 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL8003782 | 1.00 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL29740660 | 1.00 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL29548827 | 1.00 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL29351291 | 1.00 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL8187 | 1.00 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL27370819 | 1.00 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11730055-B2 | Dopant, charge transfer salt and organic electronic device | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2023-08-15 | — | — | US | disclosed |
| US-20180147225-A1 | USE OF NAD PRECURSORS FOR BREAST ENHANCEMENT | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11730055-B2 | Dopant, charge transfer salt and organic electronic device | CHRM1, SLC6A3, DRD1 | ADH1A 1249/4885LMNA 4005/4885PMP22 2797/4885 |
| US-20180147225-A1 | USE OF NAD PRECURSORS FOR BREAST ENHANCEMENT | NQO1, NNT, NAMPT | ADH1A 761/4885LMNA 2013/4885PMP22 2794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.